Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

• Published in: Cancer research (Chicago, Ill.) Vol. 74; no. 20; pp. 5746 - 5757
• Main Authors: Wang, Bin, Wang, Qiang, Wang, Zhe, Jiang, Jun, Yu, Shi-Cang, Ping, Yi-Fang, Yang, Jing, Xu, Sen-Lin, Ye, Xian-Zong, Xu, Chuan, Yang, Lang, Qian, Cheng, Wang, Ji Ming, Cui, You-Hong, Zhang, Xia, Bian, Xiu-Wu
• Format: Journal Article
• Language: English
• Published: United States 15.10.2014
• Subjects: Adult; Aged; Aged, 80 and over; Animals; Breast Neoplasms - immunology; Breast Neoplasms - pathology; Female; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens Class I - metabolism; Humans; K562 Cells; Killer Cells, Natural - immunology; Lung Neoplasms - immunology; Lung Neoplasms - secondary; Mice, Inbred NOD; Mice, SCID; MicroRNAs - metabolism; Middle Aged; Neoplasm Transplantation; Neoplastic Stem Cells - immunology; Neoplastic Stem Cells - pathology; RNA Interference; Tumor Escape; Young Adult
• ISSN: 0008-5472; 1538-7445; 1538-7445
• DOI: 10.1158/0008-5472.CAN-13-2563

Breast cancer stem-like cells (BCSC) are crucial for metastasis but the underlying mechanisms remain elusive. Here, we report that tumor-infiltrating natural killer (NK) cells failed to limit metastasis and were not associated with improved therapeutic outcome of BCSC-rich breast cancer. Primary BCSCs were resistant to cytotoxicity mediated by autologous/allogeneic NK cells due to reduced expression of MICA and MICB, two ligands for the stimulatory NK cell receptor NKG2D. Furthermore, the downregulation of MICA/MICB in BCSCs was mediated by aberrantly expressed oncogenic miR20a, which promoted the resistance of BCSC to NK cell cytotoxicity and resultant lung metastasis. The breast cancer cell differentiation–inducing agent, all-trans retinoic acid, restored the miR20a–MICA/MICB axis and sensitized BCSC to NK cell–mediated killing, thereby reducing immune escape–associated BCSC metastasis. Together, our findings reveal a novel mechanism for immune escape of human BCSC and identify the miR20a–MICA/MICB signaling axis as a therapeutic target to limit metastatic breast cancer. Cancer Res; 74(20); 5746–57. ©2014 AACR.